Replies to post #15672 on GTC Biotherapeutics (fka GTCB)

[croumagnon]

We are clearly all in the dark as to why LEO is turning the trials over to LFB but what is clear is that sales in the EU have been abysmal to non-existent under LEO's stewardship so that has to make one wonder as to how committed was LEO to the project overall. Morover, had LEO reached the stage of seeing a huge potential for DIC, I am sure they would not be relinquishing that right even in this economy.

Therefore, we have to assume that either LEO is generally disappointed with ATryn or else that their business interest lies elsewhere in this economy. Nevertheless, whichever way we sugar coat it, this can not be viewed as sometrhing good in spite of LFB's "support"...

[Lewis R Goudy]

>stench of inuendo
TWO ENS PLEASE doctor

>did ask Rustyboy
How connected! Pity such connection booted you
nought on 11/3!

[go seek]

JL... I and I expect most do not understand the charitable trust angle...

if you get the chance pls ask RB what he means.

We are dependent on management telling us the truth... // or lacking all the pieces of the puzzle, reading between the lines. Regards.

[dodah_2]

"...that it had something to do with LEO being under some charitable trust or some such."

I assume Rustyboy didn't press this explanation because one would assume Leo was "under some charitable trust or some such." before GTCB came along. At best, the explanation is disingenuous.

[biopearl]

Agreed, if plasma derived AT III really works for DIC, then Atryn will work. The charitable thing is strange, they knew the company before and this certainly seems like a cover. Not a cover for a drug that doesn't work, just a cover for a company that didn't hold up their end of the bargain because of ennui or just bad judgement re pricing. Why is it so hard to shop this platform and this drug specifically? No interest from anyone we have ever heard of (I never heard of Ovation before but I sure am glad they are around!) Is it just the Galileo syndrome (but it moves!!) or are we missing something. I think its the fear factor of accepting new technology. bp